Therapeutic antibodies and fusion proteins: what are they and how do they work

Willem A. Dik; Jon D. Laman; Herbert Hooijkaas; Vincent H. J. van der Velden

Therapeutic antibodies and fusion proteins: what are they and how do they work

Willem A. Dik^*, Jon D. Laman, Herbert Hooijkaas, Vincent H. J. van der Velden

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

18 Downloads (Pure)

Abstract

Biopharmaceutical advances have led to the development of exciting, new treatment modalities. This article summarises both the properties and mechanisms of action of the different types of therapeutic antibodies and fusion proteins.

Original language	English
Pages (from-to)	22-25
Number of pages	4
Journal	Ejhp practice
Volume	16
Issue number	6
Publication status	Published - 2010
Externally published	Yes

Keywords

EPSILON-RI EXPRESSION
RHEUMATOID-ARTHRITIS
IN-VIVO
INFLIXIMAB
ETANERCEPT
ADALIMUMAB
MANAGEMENT
DISEASE

Access to Document

Therapeutic antibodies and fusion proteinsFinal publisher's version, 177 KBLicence: Taverne

http://archive.eahp.eu/Media/Home-page/EJHP-BMJ/EJHP-Practice-archive/Issue-6-2010/Cover-Story/Therapeutic-antibodies-and-fusion-proteins-what-are-they-and-how-do-they-work

Handle.net

Persistent link

Cite this

@article{912539ffbd8a4fbd80d073a77b6a26ca,

title = "Therapeutic antibodies and fusion proteins: what are they and how do they work",

abstract = "Biopharmaceutical advances have led to the development of exciting, new treatment modalities. This article summarises both the properties and mechanisms of action of the different types of therapeutic antibodies and fusion proteins.",

keywords = "EPSILON-RI EXPRESSION, RHEUMATOID-ARTHRITIS, IN-VIVO, INFLIXIMAB, ETANERCEPT, ADALIMUMAB, MANAGEMENT, DISEASE",

author = "Dik, {Willem A.} and Laman, {Jon D.} and Herbert Hooijkaas and {van der Velden}, {Vincent H. J.}",

year = "2010",

language = "English",

volume = "16",

pages = "22--25",

journal = "Ejhp practice",

issn = "1781-9989",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "6",

}

TY - JOUR

T1 - Therapeutic antibodies and fusion proteins

T2 - what are they and how do they work

AU - Dik, Willem A.

AU - Laman, Jon D.

AU - Hooijkaas, Herbert

AU - van der Velden, Vincent H. J.

PY - 2010

Y1 - 2010

N2 - Biopharmaceutical advances have led to the development of exciting, new treatment modalities. This article summarises both the properties and mechanisms of action of the different types of therapeutic antibodies and fusion proteins.

AB - Biopharmaceutical advances have led to the development of exciting, new treatment modalities. This article summarises both the properties and mechanisms of action of the different types of therapeutic antibodies and fusion proteins.

KW - EPSILON-RI EXPRESSION

KW - RHEUMATOID-ARTHRITIS

KW - IN-VIVO

KW - INFLIXIMAB

KW - ETANERCEPT

KW - ADALIMUMAB

KW - MANAGEMENT

KW - DISEASE

M3 - Article

SN - 1781-9989

VL - 16

SP - 22

EP - 25

JO - Ejhp practice

JF - Ejhp practice

IS - 6

ER -

Therapeutic antibodies and fusion proteins: what are they and how do they work

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this